248 related articles for article (PubMed ID: 32613314)
41. A Double-Edged Sword: Neurologic Complications and Mortality in Extracorporeal Membrane Oxygenation Therapy for COVID-19-Related Severe Acute Respiratory Distress Syndrome at a Tertiary Care Center.
Masur J; Freeman CW; Mohan S
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2009-2011. PubMed ID: 32855187
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19.
Albiol N; Awol R; Martino R
Ann Hematol; 2020 Jul; 99(7):1673-1674. PubMed ID: 32462329
[No Abstract] [Full Text] [Related]
43. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
Ganzel C; Ben-Chetrit E
Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844
[No Abstract] [Full Text] [Related]
44. Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months.
Wu X; Luo D; Liu Y; Zeng Y; Gong Y
BMC Infect Dis; 2020 Oct; 20(1):774. PubMed ID: 33076856
[TBL] [Abstract][Full Text] [Related]
45. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
46. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
47. Isolated immune thrombocytopenic purpura in a young adult Covid-19 patient.
Molinaro E; Novara E; Bonometti R; Sacchi MC; Stobbione P; Lauritano EC; Boverio R
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10850-10852. PubMed ID: 33155246
[TBL] [Abstract][Full Text] [Related]
48. Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.
Phillips L; Pavisic J; Kaur D; Dorrello NV; Broglie L; Hijiya N
Blood Adv; 2020 Sep; 4(18):4358-4361. PubMed ID: 32926122
[TBL] [Abstract][Full Text] [Related]
49. Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Jerath A; Ferguson ND; Cuthbertson B
Intensive Care Med; 2020 Aug; 46(8):1563-1566. PubMed ID: 32588067
[TBL] [Abstract][Full Text] [Related]
50. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
Dal Moro F; Livi U
Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
[No Abstract] [Full Text] [Related]
51. Management of respiratory failure due to covid-19.
Wilcox SR
BMJ; 2020 May; 369():m1786. PubMed ID: 32366375
[No Abstract] [Full Text] [Related]
52. [ECMO Therapy in a Case of Severe ARDS Related to COVID-19].
Schmauss M; Müller E; Schwamborn M; Giesa C; Ewig S
Pneumologie; 2020 Jul; 74(7):423-428. PubMed ID: 32674191
[TBL] [Abstract][Full Text] [Related]
53. Respiratory Mechanics of COVID-19- versus Non-COVID-19-associated Acute Respiratory Distress Syndrome.
Haudebourg AF; Perier F; Tuffet S; de Prost N; Razazi K; Mekontso Dessap A; Carteaux G
Am J Respir Crit Care Med; 2020 Jul; 202(2):287-290. PubMed ID: 32479162
[No Abstract] [Full Text] [Related]
54. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
55. Alternative management of Covid-19 infection.
Atrah HI
Scott Med J; 2020 Aug; 65(3):72-75. PubMed ID: 32638647
[TBL] [Abstract][Full Text] [Related]
56. Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome.
Hayden A; Vyas-Lahar A; Rella V; Rudinskaya A
Lupus; 2020 Oct; 29(11):1472-1474. PubMed ID: 32640936
[TBL] [Abstract][Full Text] [Related]
57. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
De Luna G; Habibi A; Deux JF; Colard M; Pham Hung d'Alexandry d'Orengiani AL; Schlemmer F; Joher N; Kassasseya C; Pawlotsky JM; Ourghanlian C; Michel M; Mekontso-Dessap A; Bartolucci P
Am J Hematol; 2020 Jul; 95(7):876-878. PubMed ID: 32282956
[No Abstract] [Full Text] [Related]
58. Exacerbation of immune thrombocytopenia following COVID-19 vaccination.
Kuter DJ
Br J Haematol; 2021 Nov; 195(3):365-370. PubMed ID: 34075578
[TBL] [Abstract][Full Text] [Related]
59. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Cadegiani FA
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
[No Abstract] [Full Text] [Related]
60. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
